Arteriosclerosis, Vol 9, 319-325, Copyright © 1989 by American Heart Association
ARTICLES |
JH Auwerx, CA Marzetta, JE Hokanson and JD Brunzell
Department of Medicine, University of Washington, Seattle 98195.
Hepatic lipase (HL) is thought to play a role in processing very low density lipoprotein to low density lipoprotein (LDL). To analyze the relationship between HL and LDL, the density, size, and chemical composition of LDL isolated from 18 normal subjects and from three subjects with reduced or absent levels of HL activity were compared. In an HL-deficient subject, the major peak of apoprotein (apo) B- containing lipoproteins ('LDL') had a density of 1.023 g/ml and a diameter of 26.4 nm compared to male control subjects (1.044 +/- 0.006 g/ml and 25.3 +/- 0.3 nm). Two half-sisters of the HL-deficient subject with half the normal levels of HL activity had LDL that also were more buoyant and slightly larger than the LDL isolated from female control subjects. The peak density and average diameter of LDL were correlated with HL activity, consistent with the hypothesis that HL influenced formation and physical characteristics of typical LDL. Apo B-100 was the major apoprotein in the 'LDL' isolated from the HL-deficient subject and contained a greater proportion of triglyceride compared to the control subjects' LDL. The absence of HL appears to prevent the production of classical LDL. Our data support the hypothesis that HL helps determine normal LDL characteristics.
This article has been cited by other articles:
![]() |
E. K. Young, C. Chatterjee, and D. L. Sparks HDL-ApoE Content Regulates the Displacement of Hepatic Lipase from Cell Surface Proteoglycans Am. J. Pathol., July 1, 2009; 175(1): 448 - 457. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Crawford, A. S. Nord, M. D. Badzioch, J. Ranchalis, L. A. McKinstry, M. Ahearn, C. Bertucci, C. Shephard, M. Wong, M. J. Rieder, et al. A common VLDLR polymorphism interacts with APOE genotype in the prediction of carotid artery disease risk J. Lipid Res., March 1, 2008; 49(3): 588 - 596. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Albers, S. M. Marcovina, G. Imperatore, B. M. Snively, J. Stafford, W. Y. Fujimoto, E. J. Mayer-Davis, D. B. Petitti, C. Pihoker, L. Dolan, et al. Prevalence and Determinants of Elevated Apolipoprotein B and Dense Low-Density Lipoprotein in Youths with Type 1 and Type 2 Diabetes J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 735 - 742. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Q. Purnell, L. B. Bland, M. Garzotto, D. Lemmon, E. M. Wersinger, C. W. Ryan, J. D. Brunzell, and T. M. Beer Effects of transdermal estrogen on levels of lipids, lipase activity, and inflammatory markers in men with prostate cancer J. Lipid Res., February 1, 2006; 47(2): 349 - 355. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Rozek, T. S. Hatsukami, R. J. Richter, J. Ranchalis, K. Nakayama, L. A. McKinstry, D. A. Gortner, E. Boyko, G. D. Schellenberg, C. E. Furlong, et al. The correlation of paraoxonase (PON1) activity with lipid and lipoprotein levels differs with vascular disease status J. Lipid Res., September 1, 2005; 46(9): 1888 - 1895. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. C. Broedl, C. Maugeais, J. S. Millar, W. Jin, R. E. Moore, I. V. Fuki, D. Marchadier, J. M. Glick, and D. J. Rader Endothelial Lipase Promotes the Catabolism of ApoB-Containing Lipoproteins Circ. Res., June 25, 2004; 94(12): 1554 - 1561. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. Dichek, K. Qian, and N. Agrawal The bridging function of hepatic lipase clears plasma cholesterol in LDL receptor-deficient "apoB-48-only" and "apoB-100-only" mice J. Lipid Res., March 1, 2004; 45(3): 551 - 560. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rizzo, J. M. Taylor, C. M. Barbagallo, K. Berneis, P. J. Blanche, and R. M. Krauss Effects on Lipoprotein Subclasses of Combined Expression of Human Hepatic Lipase and Human apoB in Transgenic Rabbits Arterioscler Thromb Vasc Biol, January 1, 2004; 24(1): 141 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Q. Purnell, D. S. Weigle, P. Breen, and D. E. Cummings Ghrelin Levels Correlate with Insulin Levels, Insulin Resistance, and High-Density Lipoprotein Cholesterol, But Not with Gender, Menopausal Status, or Cortisol Levels in Humans J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5747 - 5752. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Hokanson, M. I. Kamboh, S. Scarboro, R. H. Eckel, and R. F. Hamman Effects of the Hepatic Lipase Gene and Physical Activity on Coronary Heart Disease Risk Am. J. Epidemiol., November 1, 2003; 158(9): 836 - 843. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. L. Ruel, P. Couture, C. Gagne, Y. Deshaies, J. Simard, R. A. Hegele, and B. Lamarche Characterization of a novel mutation causing hepatic lipase deficiency among French Canadians J. Lipid Res., August 1, 2003; 44(8): 1508 - 1514. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Sibley, J. P. Palmer, I. B. Hirsch, and J. D. Brunzell Visceral Obesity, Hepatic Lipase Activity, and Dyslipidemia in Type 1 Diabetes J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3379 - 3384. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Deeb, A. Zambon, M. C. Carr, A. F. Ayyobi, and J. D. Brunzell Hepatic lipase and dyslipidemia: interactions among genetic variants, obesity, gender, and diet J. Lipid Res., July 1, 2003; 44(7): 1279 - 1286. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Herbst, J. K. Amory, J. D. Brunzell, H. A. Chansky, and W. J. Bremner Testosterone administration to men increases hepatic lipase activity and decreases HDL and LDL size in 3 wk Am J Physiol Endocrinol Metab, June 1, 2003; 284(6): E1112 - E1118. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Berneis and R. M. Krauss Metabolic origins and clinical significance of LDL heterogeneity J. Lipid Res., September 1, 2002; 43(9): 1363 - 1379. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Skeggs and R. E. Morton LDL and HDL enriched in triglyceride promote abnormal cholesterol transport J. Lipid Res., August 1, 2002; 43(8): 1264 - 1274. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Carr, J. E. Hokanson, A. Zambon, S. S. Deeb, P. H. R. Barrett, J. Q. Purnell, and J. D. Brunzell The Contribution of Intraabdominal Fat to Gender Differences in Hepatic Lipase Activity and Low/High Density Lipoprotein Heterogeneity J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2831 - 2837. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. Dichek, S. M. Johnson, H. Akeefe, G. T. Lo, E. Sage, C. E. Yap, and R. W. Mahley Hepatic lipase overexpression lowers remnant and LDL levels by a noncatalytic mechanism in LDL receptor-deficient mice J. Lipid Res., February 1, 2001; 42(2): 201 - 210. [Abstract] [Full Text] |
||||
![]() |
A. Zambon, S. S. Deeb, A. Bensadoun, K. E. Foster, and J. D. Brunzell In vivo evidence of a role for hepatic lipase in human apoB-containing lipoprotein metabolism, independent of its lipolytic activity J. Lipid Res., December 1, 2000; 41(12): 2094 - 2099. [Abstract] [Full Text] |
||||
![]() |
K. Winkler, B. Wetzka, M. M. Hoffmann, I. Friedrich, M. Kinner, M. W. Baumstark, H. Wieland, W. März, and H. P. Zahradnik Low Density Lipoprotein (LDL) Subfractions during Pregnancy: Accumulation of Buoyant LDL with Advancing Gestation J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4543 - 4550. [Abstract] [Full Text] |
||||
![]() |
B. M. Schamberger, H. C. Geiss, M. M. Ritter, P. Schwandt, and K. G. Parhofer Influence of LDL apheresis on LDL subtypes in patients with coronary heart disease and severe hyperlipoproteinemia J. Lipid Res., May 1, 2000; 41(5): 727 - 733. [Abstract] [Full Text] |
||||
![]() |
J. Q. Purnell, S. E. Kahn, J. J. Albers, D. N. Nevin, J. D. Brunzell, and R. S. Schwartz Effect of Weight Loss with Reduction of Intra-Abdominal Fat on Lipid Metabolism in Older Men J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 977 - 982. [Abstract] [Full Text] |
||||
![]() |
H. Allayee, K. M. Dominguez, B. E. Aouizerat, R. M. Krauss, J. I. Rotter, J. Lu, R. M. Cantor, T. W. A. de Bruin, and A. J. Lusis Contribution of the hepatic lipase gene to the atherogenic lipoprotein phenotype in familial combined hyperlipidemia J. Lipid Res., February 1, 2000; 41(2): 245 - 252. [Abstract] [Full Text] |
||||
![]() |
A. Zambon, J. E. Hokanson, B. G. Brown, and J. D. Brunzell Evidence for a New Pathophysiological Mechanism for Coronary Artery Disease Regression : Hepatic Lipase–Mediated Changes in LDL Density Circulation, April 20, 1999; 99(15): 1959 - 1964. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. A. Amar, K. A. Dugi, C. C. Haudenschild, R. D. Shamburek, B. Foger, M. Chase, A. Bensadoun, R. F. Hoyt , Jr., H. B. Brewer , Jr., and S. Santamarina-Fojo Hepatic lipase facilitates the selective uptake of cholesteryl esters from remnant lipoproteins in apoE-deficient mice J. Lipid Res., December 1, 1998; 39(12): 2436 - 2442. [Abstract] [Full Text] |
||||
![]() |
S. Qiu, N. Bergeron, L. Kotite, R. M. Krauss, A. Bensadoun, and R. J. Havel Metabolism of lipoproteins containing apolipoprotein B in hepatic lipase-deficient mice J. Lipid Res., August 1, 1998; 39(8): 1661 - 1668. [Abstract] [Full Text] |
||||
![]() |
H. L. Dichek, W. Brecht, J. Fan, Z.-S. Ji, S. P. A. McCormick, H. Akeefe, L. Conzo, D. A. Sanan, K. H. Weisgraber, S. G. Young, et al. Overexpression of Hepatic Lipase in Transgenic Mice Decreases Apolipoprotein B-containing and High Density Lipoproteins. EVIDENCE THAT HEPATIC LIPASE ACTS AS A LIGAND FOR LIPOPROTEIN UPTAKE J. Biol. Chem., January 23, 1998; 273(4): 1896 - 1903. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Packard and J. Shepherd Lipoprotein Heterogeneity and Apolipoprotein B Metabolism Arterioscler Thromb Vasc Biol, December 1, 1997; 17(12): 3542 - 3556. [Abstract] [Full Text] |
||||
![]() |
C. S. Moran, J. H. Campbell, and G. R. Campbell Human Leukemia Inhibitory Factor Upregulates LDL Receptors on Liver Cells and Decreases Serum Cholesterol in the Cholesterol-Fed Rabbit Arterioscler Thromb Vasc Biol, July 1, 1997; 17(7): 1267 - 1273. [Abstract] [Full Text] |
||||
![]() |
P. T. Williams and R. M. Krauss Associations of Age, Adiposity, Menopause, and Alcohol Intake With Low-Density Lipoprotein Subclasses Arterioscler Thromb Vasc Biol, June 1, 1997; 17(6): 1082 - 1090. [Abstract] [Full Text] |
||||
![]() |
L. K. Kwong, D. N. Ridinger, M. Bandhauer, J. H. Ward, W. E. Samlowski, P.-H. Iverius, H. Pritchard, and D. E. Wilson Acute Dyslipoproteinemia Induced by Interleukin-2: Lecithin:Cholesteryl Acyltransferase, Lipoprotein Lipase, and Hepatic Lipase Deficiencies J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1572 - 1581. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Gardner, S. P. Fortmann, and R. M. Krauss Association of Small Low-Density Lipoprotein Particles With the Incidence of Coronary Artery Disease in Men and Women JAMA, September 18, 1996; 276(11): 875 - 881. [Abstract] [PDF] |
||||
![]() |
W. H. Capell, A. Zambon, M. A. Austin, J. D. Brunzell, and J. E. Hokanson Compositional Differences of LDL Particles in Normal Subjects With LDL Subclass Phenotype A and LDL Subclass Phenotype B Arterioscler Thromb Vasc Biol, August 1, 1996; 16(8): 1040 - 1046. [Abstract] [Full Text] |
||||
![]() |
H.-O. Mowri, J. R. Patsch, A. M. Gotto Jr, and W. Patsch Apolipoprotein A-II Influences the Substrate Properties of Human HDL2 and HDL3 for Hepatic Lipase Arterioscler Thromb Vasc Biol, June 1, 1996; 16(6): 755 - 762. [Abstract] [Full Text] |
||||
![]() |
K.-i. Hirano, S. Yamashita, Y. Kuga, N. Sakai, S. Nozaki, S. Kihara, T. Arai, K. Yanagi, S. Takami, M. Menju, et al. Atherosclerotic Disease in Marked Hyperalphalipoproteinemia : Combined Reduction of Cholesteryl Ester Transfer Protein and Hepatic Triglyceride Lipase Arterioscler Thromb Vasc Biol, November 1, 1995; 15(11): 1849 - 1856. [Abstract] [Full Text] |
||||
![]() |
K. A. Dugi, H.én L. Dichek, and S. Santamarina-Fojo Human Hepatic and Lipoprotein Lipase: The Loop Covering the Catalytic Site Mediates Lipase Substrate Specificity J. Biol. Chem., October 27, 1995; 270(43): 25396 - 25401. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tilly-Kiesi, Z. Qiuping, S. Ehnholm, J. Kahri, S. Lahdenpera, C. Ehnholm, and M.-R. Taskinen ApoA-IHelsinki (Lys107->0) Associated With Reduced HDL Cholesterol and LpA-I:A-II Deficiency Arterioscler Thromb Vasc Biol, September 1, 1995; 15(9): 1294 - 1306. [Abstract] [Full Text] |
||||
![]() |
B. L. Vaisman, H.-G. Klein, M. Rouis, A. M. Bérard, M. R. Kindt, G. D. Talley, S. M. Meyn, R. F. HoytJr., S. M. Marcovina, J. J. Albers, et al. Overexpression of Human Lecithin Cholesterol Acyltransferase Leads to Hyperalphalipoproteinemia in Transgenic Mice J. Biol. Chem., May 19, 1995; 270(20): 12269 - 12275. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Homanics, H. V. de Silva, J.ús Osada, S. H. Zhang, H. Wong, J. Borensztajn, and N. Maeda Mild Dyslipidemia in Mice following Targeted Inactivation of the Hepatic Lipase Gene J. Biol. Chem., February 17, 1995; 270(7): 2974 - 2980. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Slyper Low-Density Lipoprotein Density and Atherosclerosis: Unraveling the Connection JAMA, July 27, 1994; 272(4): 305 - 308. [Abstract] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1989 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |